Zobrazeno 1 - 10
of 1 037
pro vyhledávání: '"Coster, I."'
Autor:
Lipovac M; Center for the Evaluation of Vaccination (CEV), Vaccine & Infectious Disease Institute (VAXINFECTIO), Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk, Antwerp 2610, Belgium. Electronic address: Marijana.lipovac@uantwerpen.be., Téblick L; Center for the Evaluation of Vaccination (CEV), Vaccine & Infectious Disease Institute (VAXINFECTIO), Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk, Antwerp 2610, Belgium., Bell M; Center for the Evaluation of Vaccination (CEV), Vaccine & Infectious Disease Institute (VAXINFECTIO), Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk, Antwerp 2610, Belgium., Van Caesbroeck A; Center for the Evaluation of Vaccination (CEV), Vaccine & Infectious Disease Institute (VAXINFECTIO), Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk, Antwerp 2610, Belgium., De Smet A; Center for the Evaluation of Vaccination (CEV), Vaccine & Infectious Disease Institute (VAXINFECTIO), Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk, Antwerp 2610, Belgium., Van Keer S; Center for the Evaluation of Vaccination (CEV), Vaccine & Infectious Disease Institute (VAXINFECTIO), Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk, Antwerp 2610, Belgium., Delputte P; Laboratory for Microbiology, Parasitology and Hygiene (LMPH), Infla-Med Center of Excellence, Faculty of Pharmaceutical, Biomedical and Veterinary Sciences, University of Antwerp, Wilrijk, Antwerp 2610, Belgium., De Coster I; Center for the Evaluation of Vaccination (CEV), Vaccine & Infectious Disease Institute (VAXINFECTIO), Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk, Antwerp 2610, Belgium., Tjalma WAA; Multidisciplinary Breast Clinic, Gynecological Oncology Unit, Department of Obstetrics and Gynecology, Antwerp University Hospital (UZA) (Belgium), Molecular Imaging, Pathology, Radiotherapy, and Oncology (MIPRO), Faculty of Medicine and Health Sciences, University of Antwerp, Belgium., Vorsters A; Center for the Evaluation of Vaccination (CEV), Vaccine & Infectious Disease Institute (VAXINFECTIO), Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk, Antwerp 2610, Belgium.
Publikováno v:
Journal of virological methods [J Virol Methods] 2024 Sep; Vol. 329, pp. 115003. Date of Electronic Publication: 2024 Jul 26.
Autor:
Steenackers K; Centre for Evaluation of Vaccination, University of Antwerp, Drie Eikenstraat 663, 2650 Edegem, Belgium., Hanning N; Centre for Evaluation of Vaccination, University of Antwerp, Drie Eikenstraat 663, 2650 Edegem, Belgium., Bruckers L; Data Science Institute, UHasselt, Agoralaan Gebouw D, 3590 Diepenbeek, Belgium., Desombere I; Laboratory Immune Response, Department of Infectious Diseases in Humans, Sciensano, Rue Juliette Wytsmanstraat 14, 1050 Brussels, Belgium., Marchant A; European Plotkin Institute for Vaccinology, Université libre de Bruxelles, Rte de Lennik 900, 1070 Anderlecht, Belgium., Ariën KK; Virology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine, Nationalestraat 155, 2000 Antwerp, Belgium., Georges D; European Plotkin Institute for Vaccinology, Université libre de Bruxelles, Rte de Lennik 900, 1070 Anderlecht, Belgium; Laboratory of Enzymology and Protein Folding, Centre for Protein Engineering, InBioS, University of Liège, Bât.B6c Quartier Agora, allée du six Août 11, 4000 Liège, Belgium., Soentjens P; Department of Clinical Sciences, Institute of Tropical Medicine, Kronenburgstraat 43, 2000 Antwerp, Belgium., D'Onofrio V; Center for Vaccinology, Ghent University and Ghent University Hospital, Corneel Heymanslaan 10, 9000 Ghent, Belgium., Hites M; Université libre de Bruxelles, Av. Franklin Roosevelt 50, 1050 Bruxelles, Belgium; Clinic of Infectious Diseases, Hôpital Universitaire de Bruxelles, Route de Lennik 808, 1070 Bruxelles, Belgium., Berens-Riha N; Department of Clinical Sciences, Institute of Tropical Medicine, Kronenburgstraat 43, 2000 Antwerp, Belgium., De Coster I; Centre for Evaluation of Vaccination, University of Antwerp, Drie Eikenstraat 663, 2650 Edegem, Belgium., Damme PV; Centre for Evaluation of Vaccination, University of Antwerp, Drie Eikenstraat 663, 2650 Edegem, Belgium. Electronic address: pierre.vandamme@uantwerpen.be.
Publikováno v:
Vaccine [Vaccine] 2024 Nov 14; Vol. 42 (25), pp. 126117. Date of Electronic Publication: 2024 Jul 16.
Lassa fever research priorities: towards effective medical countermeasures by the end of the decade.
Autor:
Moore KA; Center for Infectious Disease Research and Policy, University of Minnesota, Minneapolis, MN, USA. Electronic address: kamoore@umn.edu., Ostrowsky JT; Center for Infectious Disease Research and Policy, University of Minnesota, Minneapolis, MN, USA., Mehr AJ; Center for Infectious Disease Research and Policy, University of Minnesota, Minneapolis, MN, USA., Johnson RA; Center for Infectious Disease Research and Policy, University of Minnesota, Minneapolis, MN, USA., Ulrich AK; Center for Infectious Disease Research and Policy, University of Minnesota, Minneapolis, MN, USA., Moua NM; Center for Infectious Disease Research and Policy, University of Minnesota, Minneapolis, MN, USA., Fay PC; Infectious Disease Strategic Programme, Wellcome Trust, London, UK., Hart PJ; Infectious Disease Strategic Programme, Wellcome Trust, London, UK., Golding JP; Infectious Disease Strategic Programme, Wellcome Trust, London, UK., Benassi V; World Health Organization, Geneva, Switzerland., Preziosi MP; World Health Organization, Geneva, Switzerland., Adetifa IM; Nigeria Centre for Disease Control & Prevention, Abuja, Nigeria., Akpede GO; Ambrose Alli University, Ekpoma, Nigeria; Institute of Viral and Emergent Pathogens Control and Research (formerly, Institute of Lassa Fever Research and Control), Irrua Specialist Teaching Hospital, Irrua, Nigeria., Ampofo WK; University of Ghana, Accra, Ghana., Asogun DA; Irrua Specialist Teaching Hospital, Irrua, Nigeria., Barrett ADT; Sealy Institute for Vaccine Sciences and Department of Pathology, University of Texas Medical Branch, Galveston, TX, USA., Bausch DG; FIND, Geneva, Switzerland; Department of Disease Control, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, UK., de Coster I; Centre for the Evaluation of Vaccination, University of Antwerp, Antwerp, Belgium., Emperador DM; FIND, Geneva, Switzerland., Feldmann H; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, USA., Fichet-Calvet E; Bernhard-Nocht Institute for Tropical Medicine, Hamburg, Germany., Formenty PBH; World Health Organization, Geneva, Switzerland., Garry RF; Tulane University, New Orleans, LA, USA; Zalgen Labs, Frederick, MD, USA; Global Viral Network, Baltimore, MD, USA., Grant DS; Kenema Government Hospital, Ministry of Health and Sanitation, Freetown, Sierra Leone; College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown, Sierra Leone., Günther S; Bernhard-Nocht Institute for Tropical Medicine, Hamburg, Germany., Gupta SB; lnternational AIDS Vaccine Initiative, New York, NY, USA., Jaspard M; The Alliance for International Medical Action, Dakar, Senegal; Saint-Antoine Hospital, Infectious Disease Department, Assistance Publique-Hôpitaux de Paris, Paris, France; INSERM Unit 1136 Institut Pierre Louis D'Epidémiologie et de Sante Publique, Paris, France., Mazzola LT; FIND, Geneva, Switzerland., Okogbenin SA; Irrua Specialist Teaching Hospital, Irrua, Nigeria., Roth C; UK Foreign, Commonwealth and Development Office, London, UK., Schmaljohn CS; Integrated Research Facility at Fort Detrick, National Institute of Allergy and Infectious Diseases, Frederick, Maryland, USA., Osterholm MT; Center for Infectious Disease Research and Policy, University of Minnesota, Minneapolis, MN, USA.
Publikováno v:
The Lancet. Infectious diseases [Lancet Infect Dis] 2024 Jul 01. Date of Electronic Publication: 2024 Jul 01.
Autor:
Téblick L; Centre for the Evaluation of Vaccination (CEV), Vaccine & Infectious Disease Institute (VAXINFECTIO), Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium., Pattyn J; Centre for the Evaluation of Vaccination (CEV), Vaccine & Infectious Disease Institute (VAXINFECTIO), Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium., Van Keer S; Centre for the Evaluation of Vaccination (CEV), Vaccine & Infectious Disease Institute (VAXINFECTIO), Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium., De Smet A; Centre for the Evaluation of Vaccination (CEV), Vaccine & Infectious Disease Institute (VAXINFECTIO), Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium., De Coster I; Centre for the Evaluation of Vaccination (CEV), Vaccine & Infectious Disease Institute (VAXINFECTIO), Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium., Tjalma WAA; Multidisciplinary Breast Clinic, Gynecological Oncology Unit, Department of Obstetrics and Gynecology. Antwerp University Hospital (UZA) (Belgium), Molecular Imaging, Pathology, Radiotherapy, and Oncology (MIPRO), Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium., Rajbhandari I; Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA., Panicker G; Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA., Unger ER; Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA., Vorsters A; Centre for the Evaluation of Vaccination (CEV), Vaccine & Infectious Disease Institute (VAXINFECTIO), Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.
Publikováno v:
Journal of medical virology [J Med Virol] 2023 Oct; Vol. 95 (10), pp. e29133.
Publikováno v:
The journal of adhesive dentistry [J Adhes Dent] 2023 Jun 30; Vol. 25, pp. 133-146. Date of Electronic Publication: 2023 Jun 30.
Autor:
Tschismarov R; Themis Bioscience, Vienna, Austria, a subsidiary of Merck & Co, Rahway, NJ, USA. Electronic address: roland.tschismarov@themisbio.com., Van Damme P; Center for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium., Germain C; Unité de Biologie des Infections Virales Emergentes, Institut Pasteur, Lyon, France; Centre International de Recherche en Infectiologie, Université de Lyon, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, Lyon, France., De Coster I; Center for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium., Mateo M; Unité de Biologie des Infections Virales Emergentes, Institut Pasteur, Lyon, France; Centre International de Recherche en Infectiologie, Université de Lyon, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, Lyon, France., Reynard S; Unité de Biologie des Infections Virales Emergentes, Institut Pasteur, Lyon, France; Centre International de Recherche en Infectiologie, Université de Lyon, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, Lyon, France., Journeaux A; Unité de Biologie des Infections Virales Emergentes, Institut Pasteur, Lyon, France., Tomberger Y; Themis Bioscience, Vienna, Austria, a subsidiary of Merck & Co, Rahway, NJ, USA., Withanage K; Center for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium., Haslwanter D; Themis Bioscience, Vienna, Austria, a subsidiary of Merck & Co, Rahway, NJ, USA., Terler K; Themis Bioscience, Vienna, Austria, a subsidiary of Merck & Co, Rahway, NJ, USA., Schrauf S; Themis Bioscience, Vienna, Austria, a subsidiary of Merck & Co, Rahway, NJ, USA., Müllner M; Themis Bioscience, Vienna, Austria, a subsidiary of Merck & Co, Rahway, NJ, USA., Tauber E; Themis Bioscience, Vienna, Austria, a subsidiary of Merck & Co, Rahway, NJ, USA., Ramsauer K; Themis Bioscience, Vienna, Austria, a subsidiary of Merck & Co, Rahway, NJ, USA., Baize S; Unité de Biologie des Infections Virales Emergentes, Institut Pasteur, Lyon, France; Centre International de Recherche en Infectiologie, Université de Lyon, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, Lyon, France.
Publikováno v:
Lancet (London, England) [Lancet] 2023 Apr 15; Vol. 401 (10384), pp. 1267-1276. Date of Electronic Publication: 2023 Mar 16.
Autor:
Erdem R; PATH, Center for Vaccine Innovation and Access, Seattle, WA, USA., De Coster I; Vaccine & Infectious Disease Institute, Centre for the Evaluation of Vaccination, University of Antwerp, Edegem, Belgium. Electronic address: ilse.decoster@uantwerpen.be., Withanage K; Vaccine & Infectious Disease Institute, Centre for the Evaluation of Vaccination, University of Antwerp, Edegem, Belgium., Mercer LD; PATH, Center for Vaccine Innovation and Access, Seattle, WA, USA., Marchant A; Institute for Medical Immunology, Université libre de Bruxelles, Brussels, Belgium., Taton M; Institute for Medical Immunology, Université libre de Bruxelles, Brussels, Belgium., Cools N; Vaccine & Infectious Disease Institute, Laboratory of Experimental Hematology, University of Antwerp, Wilrijk, Belgium., Lion E; Vaccine & Infectious Disease Institute, Laboratory of Experimental Hematology, University of Antwerp, Wilrijk, Belgium., Cassels F; PATH, Center for Vaccine Innovation and Access, Seattle, WA, USA., Higgins D; PATH, Center for Vaccine Innovation and Access, Seattle, WA, USA., Ivinson K; PATH, Center for Vaccine Innovation and Access, Seattle, WA, USA., Locke E; PATH, Center for Vaccine Innovation and Access, Seattle, WA, USA., Mahmood K; PATH, Center for Vaccine Innovation and Access, Seattle, WA, USA., Wright PF; Dartmouth College, Lebanon, NH, USA., Gast C; PATH, Center for Vaccine Innovation and Access, Seattle, WA, USA., White JA; PATH, Center for Vaccine Innovation and Access, Seattle, WA, USA., Ackerman ME; Dartmouth College, Lebanon, NH, USA., Konopka-Anstadt JL; Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Mainou BA; Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Van Damme P; Vaccine & Infectious Disease Institute, Centre for the Evaluation of Vaccination, University of Antwerp, Edegem, Belgium.
Publikováno v:
Vaccine [Vaccine] 2023 Mar 03; Vol. 41 (10), pp. 1657-1667. Date of Electronic Publication: 2023 Feb 04.
Autor:
Brickley EB; Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, United Kingdom., Connor RI; Department of Pediatrics, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA., Wieland-Alter W; Department of Pediatrics, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA., Weiner JA; Thayer School of Engineering, Dartmouth College, Hanover, New Hampshire, USA., Ackerman ME; Thayer School of Engineering, Dartmouth College, Hanover, New Hampshire, USA., Arita M; Department of Virology II, National Institute of Infectious Diseases, Tokyo, Japan., Gast C; PATH, Seattle, Washington, USA., De Coster I; Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium., Van Damme P; Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium., Bandyopadhyay AS; Bill & Melinda Gates Foundation, Seattle, Washington, USA., Wright PF; Department of Pediatrics, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA.
Publikováno v:
The Journal of infectious diseases [J Infect Dis] 2022 Aug 24; Vol. 226 (2), pp. 287-291.
Autor:
Withanage K; Vaccine and Infectious Disease Institute (VaxInfectio), Faculty of Medicine and Health Sciences, University of Antwerp, Antwerpen, Belgium., De Coster I; Vaccine and Infectious Disease Institute (VaxInfectio), Faculty of Medicine and Health Sciences, University of Antwerp, Antwerpen, Belgium., Cools N; Laboratory of Experimental Hematology, Vaccine and Infectious Disease Institute (VaxInfectio), Faculty of Medicine and Health Sciences, University of Antwerp, Antwerpen, Belgium., Viviani S; Independent Scientific Advisor on Vaccines, Epidemiology and Public Health, 10 Via Gramsci, I-53100 Monteriggioni, Siena, Italy., Tourneur J; Osivax, Lyon, France., Chevandier M; Osivax, Lyon, France., Lambiel M; Osivax, Lyon, France., Willems P; Osivax, Lyon, France., Le Vert A; Osivax, Lyon, France., Nicolas F; Osivax, Lyon, France., Van Damme P; Vaccine and Infectious Disease Institute (VaxInfectio), Faculty of Medicine and Health Sciences, University of Antwerp, Antwerpen, Belgium.
Publikováno v:
The Journal of infectious diseases [J Infect Dis] 2022 Aug 12; Vol. 226 (1), pp. 119-127.
Autor:
Wahid R; Center for Vaccine Innovation and Access, PATH, Seattle, WA, USA. rwahid@path.org., Mercer L; Center for Vaccine Innovation and Access, PATH, Seattle, WA, USA., Macadam A; National Institute for Biological Standards and Control (NIBSC), Hertfordshire, UK., Carlyle S; National Institute for Biological Standards and Control (NIBSC), Hertfordshire, UK., Stephens L; National Institute for Biological Standards and Control (NIBSC), Hertfordshire, UK., Martin J; National Institute for Biological Standards and Control (NIBSC), Hertfordshire, UK., Chumakov K; Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA.; Global Virus Network Center of Excellence, Baltimore, MD, USA., Laassri M; Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA., Petrovskaya S; Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA., Smits SL; Viroclinics Biosciences B.V., Rotterdam, the Netherlands., Stittelaar KJ; Viroclinics Xplore, Viroclinics Biosciences B.V., Rotterdam, the Netherlands., Gast C; Center for Vaccine Innovation and Access, PATH, Seattle, WA, USA., Weldon WC; Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Konopka-Anstadt JL; Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Steven Oberste M; Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Van Damme P; Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium., De Coster I; Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium., Rüttimann R; Fighting Infectious Diseases in Emerging Countries (FIDEC), Miami, FL, USA., Bandyopadhyay A; Bill and Melinda Gates Foundation, Seattle, WA, USA., Konz J; Center for Vaccine Innovation and Access, PATH, Seattle, WA, USA.
Publikováno v:
NPJ vaccines [NPJ Vaccines] 2021 Jul 29; Vol. 6 (1), pp. 94. Date of Electronic Publication: 2021 Jul 29.